Wake Network

Wake Network

Wake Network is a biosciences company specializing in psilocybin-assisted therapies, medicinal fungi, and genomics-based health integration, operating a flagship retreat in Trelawny, Jamaica.

Services

Wake Network offers medicinal and psychedelic fungi therapy along with genomics-based integration. The company provides tailor-made integration tools to support health and wellness journeys. Their clinical immersions, launched in March 2020, have treated over 250 patients. Wake Network specializes in psilocybin-assisted therapies designed to address conditions such as traumatic brain injury (TBI), depression, anxiety, and PTSD. They focus on making safe and effective psychedelic therapies accessible to all, aiming to establish these as the first line of treatment for mental health concerns.

Locations

Wake Network operates a flagship location in Trelawny, Jamaica. This facility features a 2,000-acre mountain retreat, a private beach, and 18 suites. The location is designed to offer clinical retreats and wellness programs. They are also building a facility in Jamaica dedicated to producing federally approved, lab-verified psilocybin.

Sustainable Practices

Wake Network employs sustainable feedback loops in fungi production to create a circular economy and generate zero waste. The company's medicinal mushrooms are organic, free of fillers, sustainably sourced, and tested for active compounds. Their decentralized farming initiatives in Jamaica, combined with an all-women mycology team, underscore their commitment to sustainability and ethical practices.

Research and Development

Wake Network has taken significant strides in research and development, including receiving conditional approval for the world's first microdosing clinical trial. Their subsidiary, MagicBio Research Inc., obtained a Health Canada exemption to research psilocybin and psilocin biosynthesis. Additionally, they announced a research collaboration with the Lieber Institute for Brain Development. Wake Network successfully completed the first legal psilocybin mushroom import into the United States and received a Certificate of Drug Registration for its microdose formulation in Jamaica.

Partnerships and Collaborations

Wake Network partners with innovative leaders and investors to produce natural medicines utilizing advanced technology. They focus on biosciences, clinical retreats, and wellness initiatives, collaborating with organizations to advance their mission of making psychedelic therapies a primary treatment option for mental health issues.

Companies similar to Wake Network